Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.491
+0.001 (0.20%)
At close: Nov 21, 2024, 4:00 PM
0.480
-0.011 (-2.24%)
After-hours: Nov 21, 2024, 6:12 PM EST
SPRB's stock price has decreased by -63.9% in the past year and price targets may not have had time to catch up.
Spruce Biosciences Analyst Ratings
Total Analysts
7
Consensus Rating
Hold
Price Target
$2.50
Upside
+409.16%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $2 | Hold | Reiterates | $2 | +307.33% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 19, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $2 | Hold | Reiterates | $2 | +307.33% | Aug 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $4 → $3 | Buy | Maintains | $4 → $3 | +511.00% | Jun 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 14, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $9 → $2 | Buy → Hold | Downgrades | $9 → $2 | +307.33% | Mar 14, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $8 → $3 | Buy | Maintains | $8 → $3 | +511.00% | Mar 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 14, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $9 → $2 | Buy → Hold | Downgrades | $9 → $2 | +307.33% | Mar 14, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 14, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 14, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $9 | Buy | Reiterates | $9 | +1,732.99% | Mar 5, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +1,732.99% | Feb 26, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +1,936.66% | Feb 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,936.66% | Nov 20, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.